The State Food and Drug Administration has conditionally approved two companies' new crown vaccine registration applications

　　The State Food and Drug Administration has conditionally approved two companies' new crown vaccine registration applications

　　Xinhua News Agency, Beijing, February 25 (Reporter Zhao Wenjun) The State Food and Drug Administration on the 25th conditionally approved the two companies' new crown vaccine registration applications.

　　The State Food and Drug Administration has conditionally approved the registration application of the new coronavirus inactivated vaccine (Vero cell) of the Sinopharm Wuhan Institute of Biological Products Co., Ltd.

The vaccine is suitable for preventing the disease (COVID-19) caused by the new coronavirus infection.

　　The State Food and Drug Administration has conditionally approved the registration application for the recombinant new coronavirus vaccine (type 5 adenovirus vector) of Cansino Biotech.

This vaccine is the first domestically-made adenovirus vector new coronavirus vaccine approved and is suitable for the prevention of diseases caused by new coronavirus infection (COVID-19).

　　According to the relevant provisions of the Vaccine Administration Law and the Drug Administration Law, the State Food and Drug Administration will conduct emergency review and approval in accordance with the special drug approval procedures, and approve the listing application with conditions.

The State Food and Drug Administration requires the holder of the vaccine marketing license to continue to carry out relevant research work, complete the conditional requirements, and submit follow-up research results in time.